Keyword: DSM


Lanxess Warns on Earnings as Buyout Talk Circles Covestro

22.06.2023 -

Two former spinoffs from Bayer were competing for headlines on Jun. 19 and 20, as specialty chemicals company Lanxess issued a profit warning amid rumors that Middle East...


DSM in Talks to Take Adare Biome

21.04.2023 -

DSM is in exclusive talks with US CDMO Adare Pharma Solutions to buy Adare Biome, a French developer and manufacture of postbiotics, for €275 million.

Markets & Companies

Chemicals M&A Review 2022 and Outlook 2023

17.03.2023 -

2021 was historic for chemical M&As, it was a record-breaking year in terms of total value of deals. Therefore, it was expected that 2022 would only build upon this...

Chemistry & Life Sciences

Investing in Growth Through Innovation

17.10.2022 -

Interview with Marc Doyle, CEO of Arxada, which was created following the carve-out and sale of Lonza Specialty Ingredients to private equity firms Bain Capital and...


Bachem Buys DSM’s Sisslerfeld Site

10.10.2022 -

Swiss peptide and oligonucleotide specialist Bachem has agreed to buy an undeveloped site in Sisslerfeld from DSM. It has completed the purchase of a first plot, with...


Calum MacLean to Head Lanxess-Advent JV

19.09.2022 -

German specialty chemicals producer Lanxess and private equity group Advent International have named Calum MacLean as CEO-designate of their planned joint venture for...


Technip Energies Buys DSM’s Biosuccinium Technology

05.09.2022 -

French engineering and technology company Technip Energies has boosted its sustainable chemicals portfolio with the purchase of DSM’s biosuccinium technology. Financial...


Arxada Expands at Visp to Continue Supplying DSM

26.08.2022 -

Swiss specialty chemicals company Arxada said it will invest 20 million Swiss francs to expand production at its Visp site following the extension of a long-term supply...